pNfH and NfL, in particular, play roles as diagnostic biomarkers in discriminating between ALS and ALS-mimics; pNfH has a higher sensitivity and specificity (90.7% and 88%, respectively) than NfL (sensitivity 85.4% and specificity 78.0%) [66,67]. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.